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Cold Atmospheric Plasma Induces 
ATP-Dependent Endocytosis of 
Nanoparticles and Synergistic 
U373MG Cancer Cell Death
Zhonglei He1,2, Kangze Liu1,2, Eline Manaloto1,2, Alan Casey2, George P. Cribaro4,  
Hugh J. Byrne  2, Furong Tian1,2,3, Carlos Barcia4, Gillian E. Conway1,2, Patrick J. Cullen1,5 & 
James F. Curtin  1,2,3
Gold nanoparticles (AuNP) have potential as both diagnostic and therapeutic vehicles. However, 
selective targeting and uptake in cancer cells remains challenging. Cold atmospheric plasma (CAP) 
can be combined with AuNP to achieve synergistic anti-cancer cytotoxicity. To explore synergistic 
mechanisms, we demonstrate both rate of AuNP uptake and total amount accumulated in U373MG 
Glioblastoma multiforme (GBM) cells are significantly increased when exposed to 75 kV CAP generated 
by dielectric barrier discharge. No significant changes in the physical parameters of AuNP were caused 
by CAP but active transport mechanisms were stimulated in cells. Unlike many other biological effects 
of CAP, long-lived reactive species were not involved, and plasma-activated liquids did not replicate 
the effect. Chemical effects induced by direct and indirect exposure to CAP appears the dominant 
mediator of enhanced uptake. Transient physical alterations of membrane integrity played a minor 
role. 3D-reconstruction of deconvoluted confocal images confirmed AuNP accumulation in lysosomes 
and other acidic vesicles, which will be useful for future drug delivery and diagnostic strategies. 
Toxicity of AuNP significantly increased by 25-fold when combined with CAP. Our data indicate that 
direct exposure to CAP activates AuNP-dependent cytotoxicity by increasing AuNP endocytosis and 
trafficking to lysosomes in U373MG cells.
Gold nanoparticles (AuNPs) can be used as diagnostic agents, radiosensitizers and drug delivery vehicles, due 
to their specific physical and chemical properties, such as strong surface plasmon resonance effect, high stability 
and low cytotoxicity1–3. AuNPs can be readily manufactured in various controllable shapes, sizes and monodis-
persity. Though non-functionalized AuNPs can show selective cytotoxicity to certain cell lines, especially cancer 
cells4, AuNPs are generally considered nontoxic to normal cells5,6. Cytotoxicity of AuNPs is size dependent, small 
AuNPs elicit higher cytotoxicity than larger AuNP. AuNPs of ~20 nm diameter elicit relatively low cytotoxicity in 
both normal and cancer cells7 and are optimal for traversing the blood brain barrier to enter the brain8. The sur-
face chemistry of AuNPs enables bio-conjugation and bio-modification, for example, conjugation of antibodies to 
assist in targeting or conjugation of chemotherapeutic or detection agents1,3. These properties underpin the emer-
gence of gold nanoparticles as promising therapeutic and diagnostic administration systems to treat neoplasms.
Plasma, a form of ionized gas, is one of the four fundamental states of matter and by far the most common 
form of matter in the universe. Initially, biomedical applications of plasma concentrated on heat and high tem-
perature, i.e. thermal plasmas, for tissue removal, sterilization, and cauterization9. Technological advances have 
allowed researchers to generate plasmas at ambient temperatures and at approximately 1.0 atmospheric pressure, 
allowing safer application to biological samples and tissues without risking thermal injury. These are known as 
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non-thermal atmospheric plasma (NTAP) or Cold Atmospheric Plasma (CAP). CAP has been investigated as a 
promising technique for various biomedical applications including tumour therapies, sterilization, wound healing 
and local viral and microbial infection control10–13. CAP generates a unique physical and chemical environment 
for exposure of biological tissues, eliciting effects such as activation of short and long lived reactive nitrogen spe-
cies (RNS, e.g. N2+, NO3 and NO, etc.) and reactive oxygen species (ROS, e.g. OH•, O and O2•, etc.), photons as 
well as generation of heat, pressure gradients, charged particles, and electrostatic and electromagnetic fields14,15, 
many of which are known to induce effective death pathways in cancer cells13.
Synergistic anti-cancer effects between AuNP and CAP have emerged as a promising potential approach in 
cancer therapy studies. Kim et al. first reported that cytotoxicity of CAP to melanoma cells was significantly 
increased (near five-fold) by combining with antibody-conjugated AuNP16. Zhu et al. showed that CAP coupled 
with drug loaded core-shell AuNP led to a significant enhancement in growth inhibition of breast cancer cells 
compared with control groups17. Other studies have also suggested that AuNP have synergistic cytotoxicity when 
combined with CAP in cancer treatment18,19. However, the effects of CAP and AuNP can vary due to the wide 
range of different AuNP, CAP-generating devices and cell lines.
The current research uses an experimental dielectric barrier discharge (DBD) plasma device, DIT 120, with a 
maximum voltage output of 120 kV at 50 Hz generated between two 15 cm diameter aluminium disk electrodes 
(Fig. 1a,b)20,21. We have previously characterised biological activities in cancer cells that are dependent and inde-
pendent of reactive species generation using this system22,23. We wished to explore the mechanism of CAP and 
AuNP induced cytotoxicity in cancer cells using our system. Using various analytical chemistry, biochemistry and 
microscopy to characterise the effects of CAP on AuNP, we provide evidence that direct exposure to CAP induces 
increased AuNP endocytosis and trafficking to lysosomes, which could be the mechanism of the synergistic cyto-
toxic effects observed in GBM U373MG cells.
Results
The effects of CAP on the physical properties of AuNP. CAP has been used to fabricate metal nan-
oparticles (e.g. gold and silver) without adding reducing agents24. Moreover, AuNPs are known to agglomerate 
upon stresses such as repeated centrifugation, dilution, dialysis, and upon contact with biological media25. We 
first explored whether exposure of 20 nm AuNP to our experimental plasma device DIT 120 altered their physical 
parameters (size, shape, surface (zeta) potential, or extent of agglomeration) in water and biological cell culture 
medium. A concentration range of AuNP (50–200 μg/ml) in water or culture medium was treated with CAP 
(75 kV, 30 s), or untreated and incubated for 24 hours prior to analysis. As evident in Fig. 1c, agglomeration was 
evident at higher concentrations (>100 μg/ml) in culture medium and no agglomeration of AuNP was evident 
even at 200 μg/ml in water. CAP did not induce any significant change in particle size and there is no evidence of 
agglomeration either in water or in culture medium (Fig. 1c, P = 0.1160 in media group, > 0.9999 in water group). 
We also confirmed that dilution of AuNPs in culture medium to 100 μg/ml and exposure to CAP (75 kV, 30 s) has 
no significant change in relation to other physical properties such as zeta potential (Fig. 1d, P > 0.05) or optical 
absorption (see Fig. S1 in the Supplementary Information). Moreover, no discernible change in physical param-
eters was evident using Scanning Transmission Electron Microscopy, nanoparticles remaining spherical with an 
average diameter of 20 nm and displaying similar degrees of dispersion across the surface of the gird (Fig. 1e). 
As AuNP were not observed to agglomerate in culture medium for concentrations AuNP ≤ 100 μg/ml and no 
changes in physical parameters were detected in response to CAP, culture medium containing up to 100 μg/ml 
AuNPs were used in subsequent experiments exploring uptake kinetics of AuNP.
Synergistic cytotoxicity when CAP and AuNP are combined. In our previous study, U373MG cells 
were exposed to CAP for between 3 and 300 s at 75 kV and the IC50 value of CAP treatment was determined to 
be 74.26 s (95% confidence range of 47.24–116.8 s)22. The toxicity measured in U373MG cells exposed to 30 s 
CAP is low (18.52%, SEM = 5.41%) (see Table S1 in the Supplementary Information). Figure 2a shows the results 
of non-linear regression analysis used to calculate IC50 values and confidence ranges for cells treated with AuNP 
alone and AuNP combined with CAP (75 kV, 30 s) (see Table S1 in the Supplementary Information). The IC50 
value for AuNP alone was 2125 μg/ml (95% confidence range: 1294–3491 μg/ml) (Inverse IC50 = ~0.471 μl/μg), 
which is in agreement with other reports that ~20 nm spherical gold nanoparticles have very low cytotoxicity 
to healthy or cancerous cells6,7. The IC50 value for AuNP combined with CAP was 81.71 μg/ml (95% confidence 
range: 53.83–124.16 μg/ml) (Inverse IC50 = ~12.238 μl/μg), ~26 times more toxic by comparing their inverse IC50. 
The dose response curve was divided into two phases of toxicity (Fig. 2a) to demonstrate synergy between CAP 
and AuNP. In the first phase, using low concentrations of AuNP (0–12.5 μg/ml), a sharp and significant drop in 
viability was observed only when cells were incubated with both CAP and increasing AuNP concentrations. The 
95% confidence intervals of the slope of CAP and AuNP treated cells during first phase (−63.57 to −33.43) was 
significantly different to AuNP only treated cells (−5.573 to 12.71). We believe this provides evidence that CAP 
and AuNP have a synergistic cytotoxicity to U373MG cells and the uptake of AuNP could reach to a threshold 
with increase concentration of AuNP.
Morphological assessment using bright-field microscopy confirmed the accumulation of AuNP in cells, but 
this was significantly greater when cells were pretreated with CAP (Fig. 2b). We therefore hypothesised that CAP 
can accelerate the uptake and accumulation of AuNPs into U373MG cells, thereby causing higher cytotoxicity. To 
explore the mechanism of synergistic cytotoxicity of CAP and AuNPs, we used 100 μg/ml AuNPs which is close 
to the IC50 value, at which no discernible physical changes to AuNP was observed.
Role of active (ATP-dependent) and passive (ATP-independent) transport mechanisms. To 
confirm the hypothesis that CAP affects enhanced AuNP uptake, and to investigate the mechanisms, Atomic 
Absorption Spectroscopy (AAS) was used to quantify the total amount of gold in cells. Intracellular AuNP 
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accumulated over time and followed a similar overall non-linear relationship for cells with or without exposure 
to CAP. We observed that CAP significantly increased both the initial rate of uptake and total amount of AuNP 
accumulated in cells (Fig. 3a).
To confirm whether active transport or passive diffusion mechanisms were involved, we used the mito-
chondrial decoupler, NaN3, to identify endocytosis, in which ATP is the rate limiting component. Meanwhile, 
cold temperature incubation (4 °C) was used to inhibit all energy-dependent uptake in cells. NaN3 inhibited 
AuNP uptake by about 50% when compared with controls (Fig. 3a). Interestingly, NaN3 treatment inhibited the 
uptake of AuNPs in both CAP-treated cells and untreated cells. No significant difference was observed between 
these two groups between 4 and 48 hours (Fig. 3a), indicating that CAP-stimulated uptake of AuNPs is mainly 
ATP-dependent. Cells were then incubated at 4 °C for 0.5, 1, 4, 6 h (cell viability was affected at longer time 
points). As expected, uptake of AuNP was significantly inhibited compared with controls (Fig. 3a). Together, we 
believe this provides evidence that an active transport mechanism, most likely endocytosis, is the major route of 
uptake of AuNP in cells, which occurred between 0 and 16 hours after incubation with AuNP, and which was stim-
ulated by CAP exposure. We could not rule out other transport mechanisms playing a minor role. For example, 
Figure 1. CAP demonstrates no significant effect on AuNPs (≤100 μg/ml) within culture medium or water. 
(a) Schematic of the DIT120 Plasma Device used in this study. (b) A photograph showing plasma generation 
(blue) and treatment on cell samples. (c) 20 nm AuNPs were diluted to different concentrations with cell culture 
medium or water. The mixed solutions were treated with CAP (75 kV, 30 s), incubated for 24 h, then measured 
the sizes by Zetasizer. (d) AuNPs were diluted in cell culture medium or water to 100 μg/ml and treated with 
CAP at 75 kV for 0, 30 s. Zeta potential was then measured by Zetasizer. (e) STEM of AuNP, from left to right: 
mixed with water; mixed with culture medium; mixed with culture medium then exposed to CAP for 75 kV, 
30 s, AuNP concentrations are 100 μg/ml. For Fig. 1c and d, Zetasizer measurements were repeated in six 
replicates. Statistical analysis was carried out using one-way ANOVA with Bonferroni’s multiple comparisons 
post-test.
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we observed a small fraction (i.e. 10%) of CAP-stimulated AuNP accumulation in cells that was not inhibited in 
either NaN3 or 4 °C-incubated cells. This second, minor CAP-dependent uptake mechanism occurs within 1-hour 
exposure to NaN3 (Fig. 3b) and 4 hours of exposure to 4 °C-incubated cells (Fig. 3c). Plasma-activated culture 
Figure 2. Cytotoxic synergy observed between CAP and AuNP. (a) U373MG cells were treated with different 
concentrations of AuNPs (0–800 μg/ml). After incubation for 48 h, cell viability was analysed using the Alamar 
Blue assay. The cell viabilities were divided into two phases (red and green) and non-linear regression was 
carried out. The 95% confidence bands are displayed using dotted lines. Significant differences in the slope 
(p < 0.05) are evident using non-toxic AuNP concentrations (0–12.5 μg/ml) which was further confirmed using 
Pearson’s Correlation test (p < 0.05). All experiments were repeated in five replicates. (b) After CAP treatment 
(75 kV, 0, 30 s) U373MG cells were incubated with 100 μg/ml AuNPs for 24 h, 48 h, then observed under optical 
microscope.
Figure 3. AAS analysis demonstrate the accelerated uptake of AuNPs into cells. (a) After CAP treatment 
(75 kV, 0, 30 s), U373MG cells were treated with 100 μg/ml AuNPs together with 1% NaN3 or without to inhibit 
endocytosis, then incubated at 37 °C or 4 °C as indicated before calculating the average amount of Au per cell 
using AAS. The uptake curves were assessed by non-linear regression analyses. All experiments were repeated 
in six replicates. (b) The short-time effects of CAP with or without 1% NaN3 were compared. (c) The uptake 
of AuNPs incubated at 4 °C for 0.5, 1, 4, 6 h. (d) The role of long-lived ROS generated by CAP on endocytosis 
in U373MG cells was determined by using Plasma activated media (PAM; 75 kV, 30 s, stored overnight) in 
place of CAP. For Fig. 3b–d, all experiments were repeated in six replicates. The statistical significances were 
assessed by two-way ANOVA with Tukey’s multiple comparison post-test (*P < 0.05, **P < 0.01, ***P < 0.001, 
****p < 0.0001).
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medium (PAM) containing AuNPs was used to treat cells to determine the role of long-lived reactive species26. As 
seen in Fig. 3d, the uptake of AuNPs in PAM showed no significant difference when compared with the control 
after 24 and 48 h incubation.
Subcellular localization of AuNPs endocytosed in response to CAP treatment. Despite the accu-
racy of using AAS to quantify to total amount of Au in a sample, one limitation with the technique is the difficulty 
in differentiating between AuNP that are loosely associated with the plasma membrane compared with intracel-
lular AuNP. To verify the uptake of intracellular AuNP, investigate the subcellular location and quantify the rate of 
uptake, we used confocal microscopy (Fig. 4). Unlabelled, citrate-capped AuNP were visualised using reflection of 
laser light from the colloid gold (red dots) and lysosomes were counterstained using LysoTracker Green, as shown 
Figure 4. Uptake and subcellular localization of AuNPs observed by confocal microscopy. (a) After CAP 
treatment (75 kV, 0, 30 s), U373MG cells were incubated with 100 μg/ml AuNPs for 24 h. Cell lysosomes 
were stained using 50 nM LysoTracker™ Green DND-26. The reflection of AuNPs was measured by confocal 
microscopy. (b) After CAP treatment (75 kV, 0, 30 s), U373MG cells were incubated with 100 μg/ml AuNPs for 
24 h, 48 h. Cells were then measured by confocal microscopy, the level of reflection of AuNPs was quantified 
using ImageJ. The statistical significance was assessed by two-way ANOVA with Tukey’s multiple comparison 
post-test (*P < 0.05, **P < 0.01, ***P < 0.001, ****p < 0.0001), n ≥ 20. (c) After exposure to CAP for 
increasing time (75 kV, 0–40 s), U373MG cells were incubated with 100 μg/ml AuNPs for 24 h. Cells were 
then measured by confocal microscopy, the level (Integrated Density) of reflection of AuNPs was quantified 
using the software, ImageJ. Statistical analysis was carried out using Pearson’s correlation, r = 0.9359, *P (two-
tailed) = 0.0193, n ≥ 20.
www.nature.com/scientificreports/
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in Fig. 4a. The absorption spectrum of 20 nm AuNPs confirmed that the absorption peak is around 520 nm, and 
that there is minimal absorbance above 600 nm (see Fig. S1 in the Supplementary Information). The reflection fil-
ter setting for AuNPs was set at 649–799 nm and the emission filter for LysoTracker Green was set at 505–530 nm. 
This allowed us to confirm that the green fluorescence signal is from LysoTracker Green (excited with argon laser) 
and red reflection is from AuNP (reflected light from HeNe laser). A significant fraction of intracellular colo-
calization was evident (yellow), indicating that the lysosomal compartment was the major destination of AuNP 
following CAP-stimulated uptake (Fig. 4a). Interestingly, some AuNPs were not located in lysosomes, suggesting 
that these AuNPs remained in early endosomes or had entered the cytosol, either by passive diffusion, transport 
mechanisms through the cell membrane or released from lysosomes subsequent to endocytosis. Significantly 
higher levels of intracellular AuNP in cells were observed following CAP treatment (Fig. 4b), in agreement with 
our AAS data. Moreover, varying the dose of CAP confirmed a significant, strong and positive correlation exists 
between exposure to CAP and subsequent AuNP uptake (Fig. 4c), Pearson’s correlation, r = 0.9359, P = 0.0193.
Z-stacked images were obtained to ensure that only intracellular AuNP were quantified. Stacked, decon-
voluted confocal images were next reconstructed using rendering software (Imaris 8.0. Bitplane) to generate 
3 dimensional reconstructions of individual cells. The presence of AuNP (red) inside lysosomes (green) was 
confirmed by rotating and sectioning the cells around the three spatial axes and projecting sections from the x, 
y and z planes of the reconstructions (Fig. 5a,b). Taken together, our data confirm that CAP induces synergistic 
Figure 5. AuNPs are incorporated within lysosomes in glioma cells. (a) 3D reconstruction of the untreated 
glioma cells visualized with dichroic channel (grey), incorporating AuNPs (red) within lysosomes (LysoTracker 
green). U373MG cells were incubated with 100 μg/ml AuNPs for 24 h, after CAP treatment (75 kV, 0, 30 s). 
Low incorporation of AuNPs inside the cells is demonstrated. High magnifications in bottom panel show 
lysosomes evidenced with green isosurface. Vertical and horizontal clipping planes reveal no red material inside 
lysosomes. Boxes at the bottom indicate the orientation of the clipping planes (b) Analogous 3D reconstruction 
of CAP-treated cells, demonstrated a significant increase of AuNPs in the entire cells and in part located inside 
lysosomes. High magnification in the bottom panel show lysosomes evidenced with green isosurface. Vertical 
and horizontal clipping planes reveal red AuNPs nanoparticles inside lysosomes. High magnification at the 
bottom panel shows lysosomes rendered with green isosurface. (c,d) The role of short and long-lived reactive 
species generated by CAP on endocytosis in U373MG cells was determined by pretreating cells with 4 mM anti-
oxidant N-Acetyl Cysteine (NAC) for 1 h before CAP treatment (75 kV, 30 s) or by indirect CAP treatment (see 
detail in Method). The level of reflection of AuNPs was quantified using the ImageJ after incubated for 24 (c) or 
48 hours (d). The statistical significance was assessed by two-way ANOVA with Tukey’s multiple comparison 
post-test (*P < 0.05, **P < 0.01, ***P < 0.001), n ≥ 20.
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cytotoxicity while-stimulating the uptake of citrate capped 20 nm AuNP through a predominantly endocytic 
mechanism, leading to trafficking of the AuNP into acidic (lysosomal) compartments of U373MG cells.
Role of physical and chemical effects of CAP on AuNP uptake. Our data indicated that long-lived 
reactive species present in plasma activated media (PAM) did not play a major role in enhanced uptake of AuNP 
(Fig. 3d). We wished to further investigate effects of CAP on AuNP endocytosis. Due to the set-up of the DBD 
plasma device, samples can either be placed directly in the plasma discharging area (direct exposure) or outside 
the plasma-discharging area (indirect exposure). Plasma sources for direct or indirect plasma treatment were pre-
viously distinguished by Fridman et al.9 and more recently by Von Woedtke et al.27. In indirect plasma treatment, 
the electrodes are part of the plasma-generating device, only and there is no significant electrical contact to the 
targeted structures, whereas in direct plasma treatment, the biological samples serve as one of the two electrodes. 
In both cases, samples are contained within a sealed reactor. Direct exposure results in direct interaction with 
UV, electric fields, electron beams, charged particles, whereas indirect exposure does not result in any interaction 
with these physical species. However, the sealed reactor system still allows the exposure of reactive species to cells. 
It has been demonstrated that ozone concentration and reactive oxygen species generated are not significantly 
different during direct or indirect CAP exposure21,28. We investigated the difference between direct and indirect 
CAP treatment on AuNP uptake to differentiate between direct physical effects and chemical (oxidation) effects. 
Our results demonstrated that AuNP uptake was significantly higher when cells were treated with indirect CAP 
exposure compared with untreated cells, suggesting that chemical effects were important in promoting endocy-
tosis (Fig. 5c,d). The enhanced AuNP uptake was consistently slightly lower compared with direct CAP exposure 
although we were not able to determine a significant difference, suggesting that any physical effects only play a 
minor role in the increased uptake of AuNP. We used N-Acetyl Cysteine (NAC), a synthetic precursor of intracel-
lular cysteine and glutathione (GSH) that replenishes intracellular GSH and scavenges reactive species as a redox 
buffer29 to remove long-lived ROS in situ during CAP treatment. This was ineffective in significantly reducing 
AuNP uptake enhanced by CAP (Fig. 5c,d), suggesting that either the oxidising environment generated by CAP 
overwhelms GSH and other intracellular anti-oxidant defences, or that NAC-insensitive chemicals produced by 
both direct and indirect contained CAP fields are the primary cause of enhanced AuNP uptake.
Discussion
AuNPs have been developed as promising theranostic agents for brain cancer therapy in diverse applications, 
such as in vivo tumour imaging, inducing radiosensitization and targeted delivery of chemotherapeutics across 
blood-brain barrier (BBB) to brain cancer cells1,30. As an emerging platform for drug delivery, the toxic effect of 
AuNP to normal cells can be minimized or eliminated by altering the size7. However, the proportion of AuNPs 
that penetrate the BBB is usually no more than 1%31. To date, efforts to enhance AuNP crossing of the BBB have 
been mainly focused on targeting AuNP to the surface receptors of endothelial cells32 and the limited success 
means that there is still need for further studying the mechanisms of crossing BBB and blood-tumour barriers, 
etc. The permeability, targeting capacity and uptake of AuNP into targeted cancer cells are the key to success clin-
ical application of AuNP. CAP treatment has been extensively investigated in cancer therapy, due to its promising 
selective capacity of killing a wide range of cancer cells13, such as carcinomas, glioblastomas, melanomas and 
hematopoietic malignancies16,33,34. In recent years, CAP has been successfully and safely used in a prospective 
clinical trial for head and neck cancer treatment and chronic wound healing, demonstrating significant benefits 
and no side-effects. Meanwhile, the synergistic anti-cancer effects between AuNP and CAP were reported in 
several previous studies16–19,35.
Although cancer cells are generally reported to be favourably sensitive to CAP induced cytotoxicity when 
compared with normal cells or tissues14, U373MG GBM cells have significantly higher resistance to CAP treat-
ment compared to other cancer cell lines22. GBM cells also show high aggressiveness and resistance to radiation 
therapy and most chemotherapies36. There is evidence in the literature that AuNPs have synergistic cytotoxicity 
combined with CAP, although the mechanisms remain to be elucidated. Therefore, we chose to study the mech-
anism of CAP, combined with AuNP, as a possible future chemotherapy delivery vehicle. In this study, we con-
firmed that combining CAP with AuNP increased around 25-fold of U373MG cell death compared to AuNP only. 
We also demonstrated that CAP treatments accelerate the endocytosis of U373MG cells by temporarily increase 
membrane permeabilisation or turnover, thereby increasing uptake and cytotoxicity of AuNP. These effects will 
be useful to induce higher selective cytotoxicity against cancer cells while increasing drug delivery efficiency and/
or imaging diagnostics for cancer therapy.
In this study, we used 20 nm citrate capped AuNPs, which not only have optimal BBB permeability and low 
toxicity, but also can rapidly enter cells, mostly by receptor-mediated endocytosis7,8,37. Therefore, 20 nm AuNPs 
can be the optimal candidate for drug delivery across BBB. We were able to confirm that the observation of the 
uptake of 20 nm citrate capped AuNPs are consistent with endocytosis and a large proportion of them were 
trapped in lysosomes in both CAP-treated and untreated U373MG cells (Figs 3, 4 and 5). We confirmed that CAP 
did not discernibly alter the physical properties of AuNP, although we did see evidence that CAP could stimulate 
low levels of non-active uptake through an ATP-independent mechanism, which may indicate some level of sur-
face modification or other physical change to AuNP and/or cell membranes. Although we were unable to detect 
physical changes to AuNP exposed to CAP, significant alterations in cell membranes after exposure to CAP were 
previously observed by others38. Our observation that synergistic cytotoxicity occurs in parallel with enhanced 
uptake suggests the two processes are linked in U373MG cells. Although, there have been no studies reported to 
date on the relative sensitivity of normal and GBM cells to CAP-induced endocytosis, it has been demonstrated 
that the significant alterations in cell membrane of GBM cells induced by CAP treatment is maintained, whereas 
the membrane alteration in normal human astrocytes E6/E7 is weaker and reversible38. More detailed mecha-
nisms regulating the uptake of nanoparticles in normal and GBM cells will be investigated in a follow-on study. A 
www.nature.com/scientificreports/
8SCIENTIFIC REPoRTS |  (2018) 8:5298  | DOI:10.1038/s41598-018-23262-0
controllable, directable CAP treatment, which is directly applied to diseased tissue, also is expected to be included 
to present the in vivo experiment in the follow-on study. At this stage, we provided a likely hypothesis as follows.
It is possible that enhanced uptake of AuNP may underpin the synergistic cytotoxicity observed, in combi-
nation with other effects such as the higher load of reactive species carried by CAP-treated AuNP. For example, 
it has been reported that AuNP are capable of trapping reactive species and extending their half-life, and thus 
helping the delivery of CAP generated reactive species into cancer cells15. It is also likely that the enhanced accu-
mulation of AuNP is caused by one of three effects attributed to CAP, i.e. reactive species, direct physical effects 
and cellular mechanism (mainly endocytosis).
Considering the potential role of reactive species, hydrogen peroxide (H2O2) was found to be capable of 
facilitating the endocytosis of polyethylenimine/oligonucleotide (PEI/ON) complexes, involving a cytoplasmic 
[Ca2+]-independent activation of calcium/calmodulin-dependent protein kinase II (CaMKII), which stimulates 
cytoskeleton contractions and transportation39. It was also found that the ROS generated in mitochondria medi-
ate the hypoxia-induced endocytosis in alveolar epithelial cells40. It is considered that CAP is capable of influ-
encing cell behaviour by generating intracellular ROS and RNS22. These studies imply that the CAP-generated 
intracellular ROS could have an impact on the enhanced endocytosis. Meanwhile, reactive species are capable of 
inducing membrane damage and increasing the permeability of cell membrane41. The reactive species generated 
in the cytoplasm or in the media can induce lipid peroxidation in membranes by oxidizing the polyunsaturated 
fatty acids. Reactive species are also able to attack membrane proteins, causing the membrane damage41. It has 
been found that the membrane lesions are capable of activating rapid endocytosis to remove damage parts and 
preserve and repair the integrity of cell membrane42. Therefore, it is possible that the chemical and physical mem-
brane damage caused by CAP could activate the membrane repair response, thus accelerating the endocytosis 
of AuNPs. Although we found that long-lived reactive species have little effect on the uptake of AuNP (Fig. 3d), 
the short-lived, highly reactive species may play a role in the stimulated uptake, which will need to be further 
elucidated.
Considering the direct physical effects, which are mainly electrical factors in DBD CAP treatment, Jinno, M et 
al. has described the roles of chemical (reactive species) and electrical effects of CAP in the CAP gene transfection 
in L-929, mouse fibroblast cells43. It was found that reactive species alone do not work, but need to be combined 
with electrical effects. Electroporation effects, which can last for a few minutes, were also found to play a role in 
gene transfection43. Computational modelling was used to determine that large pore formation in spherical cell 
membranes (i.e. 15–25 nm) can be induced in strong electric fields in silico44, a notion which has since been con-
firmed for 20 nm AuNP in vitro45. Meanwhile, it was observed that the treatment of CAP in U87 cells results in an 
uneven membrane and development of membrane pores46. Nina Recek et al. have studied the differential effects 
of CAP on cell membranes of normal human astrocytes (E6/E7) and U87 cells by atomic force microscopy. CAP 
treatment causes a temporary disappearance of microvilli in E6/E7, and unrecoverable partial cell membranes 
and cell components damage of U87 cells. The temporary pores created in membranes and membrane damage 
could be the ATP-independent mechanism that stimulates low levels of non-active uptake of AuNP during the 
first few hours after treatment with NaN3 or under low-temperature incubation (Fig. 3b,c). Moreover, it also 
known that CAP is capable of temporarily changing the polarity/potential of the membrane, which also could 
play a role in stimulating endocytosis47. As seen in Fig. 5c,d, the indirect treatment, which removes the direct 
physical effects caused by CAP, showed only slightly decreased accumulation of AuNP and no significant differ-
ence evident compared with direct treatment. It confirmed that the temporary direct physical influence caused by 
DBD CAP treatment plays only a minor role in the increased uptake of AuNP.
It is considered that the endocyosis of cells can be stimulated by CAP via reactive species and other mecha-
nisms such as membrane damage, as indicated above39,42,43. In gene transfection, the clathrin-dependent endocy-
tosis stimulated by CAP was found to be dominant in the uptake, while synergistically combining with electrical 
effects43. We observed two phases to the enhanced uptake of AuNP. Over the first one hour, we observed both 
increased endocytosis and possibly also increased passive diffusion through damaged or otherwise permeable 
membranes (Fig. 3b,c). We then observed a second phase, between 4 and 18 hours, where AuNP uptake was fur-
ther accelerated by CAP primarily though endocytosis with no evidence for further passive mechanisms before 
reaching a maximum accumulated threshold (Fig. 3a).
Taken together, we report that the synergistic cytotoxicity of AuNP and CAP is a result of enhanced endocy-
tosis and trafficking to the lysosomal compartment as well as temporarily increased membrane permeability, due 
to CAP treatment. This contributes understanding to the mechanisms of synergistic cytotoxic effects between 
CAP and nanotechnologies and identifies strategies that may be employed for the release of drugs when used in 
a drug-delivery capacity.
Methods
Cell Culture. The human brain glioblastoma cancer cell line (U373MG-CD14) cells were obtained from Dr 
Michael Carty (Trinity College Dublin). Cells were cultured in Dulbecco’s Modified Eagle’s Medium-high glucose 
(Sigma-Aldrich) supplemented with 10% foetal bovine serum (Sigma-Aldrich) and 1% penicillin and strepto-
mycin mixture (Thermo Fisher Scientific) in TC flask T25, standard for adherent cells (Sarstedt). The cultures 
were maintained under a condition of 5% (v/v) CO2 and 37 °C in a humidified incubator. Culture medium was 
changed every 2 days until reaching around 80% confluency. Cells were then brought into suspension using 0.25% 
trypsin solution (Thermo Fisher Scientific) and subcultured in new flasks.
CAP Configuration and Treatment. The CAP-DBD device used (Fig. 1a,b) is an experimental atmos-
pheric low temperature plasma generator22. It consists of two aluminium disc-electrodes (diameter 15 cm) with 
a polypropylene sheet in the middle, which is used as dielectric barrier and holder for the reactor and cell sam-
ples. The thickness of the dielectric barrier is 1.2 mm, and the distance between the two electrodes was 26.6 mm. 
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Samples were placed in a sealed reactor and treated inside or outside the plasma discharging area. The CAP 
was generated between two disc-electrodes when the high voltage was applied. Voltage was monitored using an 
InfiniVision 2000 × -Series Oscillo-scope (Agilent Technologies Inc., Santa Clara, CA, USA). TC dish 35 standard 
(35 × 10 mm, Sarstedt) was used as the cells container for CAP treatment. U373MG cells were seeded into the 
dishes at a density of 1 × 105 cells/ml and incubated overnight to allow a proper adherence (70–80% confluency). 
For direct treatment, culture medium was removed from the dishes before the CAP treatment, then the cell 
culture dishes were put between the two electrodes and treated at 75 kV for 0–40 s. The fresh culture medium 
containing 100 μg/ml AuNPs or inhibitors was added after exposing to CAP. For CAP-activated culture medium, 
the fresh culture medium were contained in TC dish 35, standard and treated with CAP at 75 kV for 30 s and 
stored overnight to remove short-live reactive species. AuNPs were added into CAP-activated media to 100 μg/ml. 
The CAP-untreated cells were then incubated with CAP-activated media containing AuNPs for 24 and 48 h. The 
indirect CAP treatment was used to determine the role of direct physical effects. To indirectly treat cells with CAP, 
the sample was treated in the reactor without the dish lid on it, and culture medium was removed before the treat-
ment. The cell culture dish was placed on the corner of the reactor, outside the plasma discharging area. During 
the treatment (75 kV, 30 s), the reactor was sealed in a high barrier polypropylene bag (B2630; Cryovac Sealed Air 
Ltd, Dunkan, SC, USA) to keep the CAP inside the reactor, and to make sure the cells were only affected by the 
short-lived and long-lived reactive species generated in air28. Fresh culture medium containing 100 μg/ml AuNPs 
was then added after indirect CAP treatment.
Gold Nanoparticles Synthesis and Characterization. 20 nm AuNPs used in this study are synthesised 
by trisodium citrate (Na3C6H5O) reduction of auric acid (HAuCl4). The typical method of AuNPs synthesis as 
follows. HAuCl4 was dissolved in water at a concentration of 0.25 mM in a clean glass flask and heated with 
magnetic stirring and brought to boiling. The corresponding amount of 5% (w/v) sodium citrate solution was 
quickly added to final 3.5:1 molar ratio of citrate to Au3 + while being keep heating and stirring. The reaction 
was completed until the colour of solution was changed from dark purple to wine red and keep stable. The gold 
colloid was then centrifuged at 10000 g for 10 min to concentrate the AuNPs stock solution to 2500 μg/ml. The 
size, absorbance curve and zeta potential of AuNPs was then determined by UV-Vis spectrometer (Shimadzu, 
UV-1800), Zetasizer (Malvern, Nano ZS) and scanning transmission electron microscopy (STEM). The AuNPs 
stock solution was diluted in water or culture medium to corresponding concentration as indicated in the relevant 
figures.
Cell Viability Assays. Cell viability was analysed using the Alamar blue assay (Thermo Fisher Scientific), 
which used a redox indicator that can generate fluorescent signal by the metabolic reduction. U373MG cells were 
plated into 96-well plates (Sarstedt) at a density of 1 × 104 cells/well (100 μl culture medium per well), and were 
incubated overnight to allow a proper adherence. The cells were then directly treated with CAP at 75 kV for 0–30 s 
at 70–80% confluency, and culture medium containing 0–100 μg/ml AuNPs was added post CAP treatment. 
Forty-eight hours late, the cells were rinsed once with phosphate buffered saline (Sigma-Aldrich), incubated for 
3 h at 37 °C with a 10% Alamar blue/90% culture medium solution. The fluorescence was then measured (excita-
tion, 530 nm; emission, 595 nm) by a Victor 3 V 1420 microplate reader (Perkin Elmer).
Atomic Absorption Spectroscopy. U373MG cells were seeded into 60 mm dishes (Sarstedt) at a density 
of 1 × 105 cells/ml and incubated for 2 days to achieving 90–100% confluency. The culture medium was removed 
and cells were directly exposed to CAP at 75 kV for corresponding time. The fresh culture medium containing 
100 μg/ml AuNPs or 0.1% (w/v) NaN3 was then replaced and incubated for 0.5–48 h at 37 °C or 4 °C as indicated. 
After treatment, cells were washed thrice with phosphate buffered saline to remove the AuNPs outside cells. Cells 
were then dissociated and collected from the culture dish using prewarmed (37 °C) 0.25% trypsin solution. The 
cell suspension was counted using hemocytometer, then transferred to 15 ml tube (Sarstedt) to measure the gold 
atomic absorbance in AAS. To verify the Au amount of the samples, five-point standard curve were first estab-
lished using 1–5 ppm standard gold colloid. The concentrations of AuNPs in samples were then calibrated by the 
standard curve as described elsewhere48.
Inhibitor Studies. To determine the uptake of AuNPs, NaN3 was used as metabolic inhibitor to inhibit 
the energy-dependent endocytosis. 20% (w/v) NaN3 stock solution was prepared in phosphate buffered saline. 
The cells were pre-incubated with 0.1% (w/v) NaN3 in prewarmed (37 °C) culture medium for 1 h. The culture 
medium was then removed during CAP treatment, then fresh media containing 0.1% (w/v) NaN3 and 100 μg/ml 
AuNPs was added into the cell culture and incubated at 37 °C as indicated. 4 °C incubation was used to inhibit 
endocytosis as a standard experiment. Cells were incubated at 4 °C for 1 h before the CAP treatment, pre-chilled 
culture medium containing 100 μg/ml AuNPs was then replaced post CAP treatment and incubated at 4 °C for 
0.5–6 h as indicated. N-Acetyl Cysteine (NAC) was used as antioxidant to remove long-lived reactive species. 4 M 
NAC stock solution was prepared in water. The cells were pre-incubated with 4 mM NAC in culture medium for 
1 h at 37 °C. The culture medium was then removed during CAP treatment. Afterward, cells were incubated in 
fresh media with 4 mM NAC and 100 μg/ml AuNPs for 24 and 48 h.
Fluorescent Dyes and Cell Imaging. Lysosomes was demonstrated using the LysoTracker™ Green 
DND-26 (Thermo Fisher Scientific). Cells were seeded in 35 mm glass-bottom dishes (Greiner Bio-One) at a 
density of 1 × 105 cells/ml overnight and treated with CAP for 0–40 s at 70–80% confluency, the fresh media 
containing 0–100 μg/ml AuNPs was then replaced and incubated for 24 h or 48 h at 37 °C as indicated. After 
treatment, the cells were rinsed thrice with phosphate buffered saline and incubated with prewarmed (37 °C) 
LysoTracker-containing (50 nM) media for 5 min at 37 °C. Cells were then washed once with phosphate buff-
ered saline and loaded with fresh phosphate buffered saline and observed using Zeiss LSM 510 confocal laser 
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scanning microscope fitted with the corresponding filter settings as follows. LysoTracker™ Green DND-26, 
excitation wavelength: 488 nm, emission filter: 505–530 nm; AuNPs, excitation wavelength: 633 nm, reflection 
filter: 649–799 nm. Plan-Apochromat 63 × /1.4 Oil Ph3 was used as objective for all samples. To determine the 
level of AuNPs reflection, around 50 cells were randomly imaged for each treatment condition and the levels of 
reflection was analysed using the ImageJ and compared with other groups.
Statistical Analysis. All data points were from at least triplicate independent samples and are presented 
and/or pooled as mean ± S.E.M unless indicated otherwise. Curve fitting and statistical analysis were carried out 
using Prism 6 (GraphPad Software). The Alpha for all tests is 0.05 and two-tailed P values were used. One-way 
ANOVA and two-way ANOVA was used to verify the significance between data points as indicated in figures 
(*P < 0.05, **P < 0.01, ***P < 0.001, ****p < 0.0001).
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